1st Quarter - Report

STANTON PARK GROUP for BARR LABORATORIES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

Generic Drug Settlements (S 316, HR 1902)

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —
ASHLIE VAN METER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1902 (110th)

Pharmacy PHA

Generic Biologics (HR 1956, S. 1695, HR 1038, S 623, HR 5629); FDA REform (HR 2900, S 1082) office of Generic Drugs funding in Agrigultural Approps. (HR 3161, S 1859)

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —
ASHLIE VAN METER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1038 (110th), H.R. 5629 (110th), H.R. 1956 (110th), H.R. 2900 (110th), S. 1695 (110th), H.R. 3161 (110th)

Science/Technology SCI

Patent Reform (HR 1908, S 1145)

LobbyistCovered position, as disclosed
BRIAN CAVEY —
JAMES DERDERIAN —
ANDREW HALATAEI —
ERIN STRAWN —
ASHLIE VAN METER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.